Physician profile
Lee R Stein
NPI 1427098318
$8,175.69
in general payments reported to CMS, 2019-2025
28 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,620 · 2020: $1,632 · 2021: $770 · 2022: $711 · 2023: $2,058 · 2024: $272 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,187 · Food and Beverage: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,187.31 |
| Food and Beverage | $1,254.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,437.94 | 2023 | Na |
| Musculoskeletal Transplant Foundation INC. | $1,373.91 | 2020 | |
| Treace Medical Concepts, INC. | $1,022.66 | 2021-2025 | |
| Stryker Corporation | $791.72 | 2019-2025 | Ortholoc 3di |
| Crossroads Extremity Systems, LLC | $592.35 | 2019 | |
| Depuy Synthes Sales INC. | $461.75 | 2022-2023 | Fibulink, Motoband, N/A |
| Trimed, INC. | $365.15 | 2019 | |
| Organogenesis INC. | $350.96 | 2019-2022 | |
| Arteriocyte Medical Systems, INC. | $333.76 | 2019-2021 | |
| Orthofix Medical, INC. | $324.96 | 2020-2024 | Physio-Stim |
| Smith+Nephew, INC. | $217.29 | 2019-2022 | |
| Kerecis Limited | $168.62 | 2022 | |
| Aroa Biosurgery Incorporated | $136.62 | 2023 | |
| Polynovo North America LLC | $105.55 | 2024 | Novosorb Btm |
| Integra Lifesciences Corporation | $80.15 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $58.54 | 2021 | |
| Medline Industries LP | $56.24 | 2019 | |
| Lightbody Medical Technologies INC | $52.27 | 2025 | |
| Biogen, INC. | $39.56 | 2025 | Vumerity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.49 | 2023 | Trulance, Xifaxan |
| Osiris Therapeutics INC. | $27.81 | 2019 | |
| Abbvie INC. | $27.60 | 2021 | |
| Dexcom, INC. | $26.44 | 2023 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $23.20 | 2023 | Ozempic, Rybelsus |
| Phadia US INC. | $19.30 | 2022 | |
| Normatec Industries, LP | $17.97 | 2019 | |
| Glaxosmithkline, LLC. | $17.66 | 2022 | |
| Bioventus LLC | $16.22 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.